CA Patent
CA2399991A1 — 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
Assigned to Pharmacia and Upjohn Co · Expires 2001-09-27 · 25y expired
What this patent protects
A compound of formula (IV) or a pharmaceutically acceptable salt thereof as defined in the specification.
USPTO Abstract
A compound of formula (IV) or a pharmaceutically acceptable salt thereof as defined in the specification.
Drugs covered by this patent
- Kalydeco (IVACAFTOR) · Vertex Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.